查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493221

骨科生物製品市场规模、份额和趋势分析报告：2024-2030 年按产品、应用、最终用途、地区和细分市场进行的预测

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

骨科生物製剂市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球骨科生物製品市场规模将达93亿美元，2024年至2030年复合年增长率为5.5%。

世界各地整形外科手术病例数量的不断增加正在推动对骨科生物製剂的需求。在美国整形外科学会 (AAOS) 2023 年年会上发表的一项研究表明，骨科医生将面临满足全关节置换术(TJA) 日益增长的需求的挑战。根据这项研究，为了满足需求，外科医生需要每五年将 TJA 病例量增加一倍或将外科医生数量增加 10%。

随着对医疗保健进步和患者治疗结果的日益关注，世界各国政府正在实施政策和倡议来促进骨科生物製剂的发展。例如，美国整形外科学会 (AAOS) 致力于以透明和科学的方式改善肌肉骨骼护理。 2020年10月，AAOS在其网站上推出了生技药品仪表板，帮助骨科医生了解生物製药治疗方法的核准情况。该倡议是 AAOS 生物製品计划的一部分，该计划为肌肉骨骼健康界提供循证指导。作为这项工作的一部分，AAOS 董事会还修订了两份与生技药品相关的立场声明。

全球老年人口的成长预计也将推动整形外科手术的需求。根据《2023年印度老化报告》，印度老年人口正快速成长，10年成长率达41%。到2050年，预计超过20%的印度人口将是老年人。随着年龄的增长，我们的肌肉和骨骼更有可能出现问题，例如骨质疏鬆症、骨关节炎和骨折。因此，对骨科生物製剂的需求将会增加。

此外，道路事故的增加预计也将补充市场的成长。美国公路交通安全管理局报告称，2023 年上半年估计有 19,515 人死于车祸。与去年同期的死亡人数 20,190 人相比，减少了约 3.3%。此外，2023 年第一季季和第二季的死亡人数均有所下降。因此，预计受伤人数的增加将增加对骨科生物製剂的需求。

市场上的主要企业正在采取联盟、供应协议和合作伙伴关係等策略，重点是增强产品形成和覆盖范围。例如，2023 年 9 月，HippoFi Inc. 与 Zimmer Biomet Holdings Inc. 合作推出了一种用于骨骼生长的合成生医材料。该生医材料预计将于 2024 年由 HippoFi 的生技药品子公司 PUR Biologics 推出。

生技药品市场亮点

  • 从产品来看，由于文明病的盛行率不断增加以及透明质酸疗法开发的进步，关节内粘稠补充疗法细分市场在 2023 年将占据最大的销售份额。
  • 从应用来看，由于退化性椎间盘疾病的盛行率不断上升，脊椎融合手术细分市场在 2023 年将占据最大的收益占有率。
  • 按最终用途划分，由于接受外科手术的患者数量增加，医院部门占据了最大的收益占有率。
  • 由于存在多个市场参与者和完善的法律规范，北美在市场上占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球骨科生物製品市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 骨科生物製剂：市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析
  • 法律规范

第四章全球骨科生物製品市场区隔分析（依产品），2018-2030

  • 定义和范围
  • 2023 年及 2030 年产品类型市场占有率分析
  • 细分仪表板
  • 全球骨科生物製品市场（依产品类型），2018-2030
  • 去矿物质骨基质（DBM）
  • 同种异体移植
  • 骨形成蛋白（BMP）
  • 关节内粘稠补充疗法
  • 合成骨替代物
  • 干细胞疗法

第 5 章 2018-2030 年全球骨科生物製品市场区隔分析（按应用）

  • 定义和范围
  • 2023 年和 2030 年应用市场占有率分析
  • 细分仪表板
  • 全球骨科生物製品市场（按应用），2018-2030
  • 脊椎融合手术
  • 创伤修復
  • 重组手术

第六章 全球骨科生物製品市场区隔分析（依最终用途），2018-2030 年

  • 定义和范围
  • 2023 年及 2030 年最终用途市场占有率分析
  • 细分仪表板
  • 全球骨科生物製品市场（依最终用途），2018-2030 年
  • 医院
  • 门诊设施

第七章全球骨科生物製品市场細項分析（按地区），2018-2030

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场简介
  • 2023 年及 2030 年骨科生物製剂市场占有率（按地区）
  • 北美洲
    • 北美骨科生物製品市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲骨科生物製品市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司简介
    • Medtronic Plc
    • DePuy Synthes
    • Zimmer Biomet
    • Stryker Corporation
    • Bioventus LLC
    • Seaspine Holdings Corporation
    • Orthofix, Inc.
    • Globus Medical
    • Arthrex, Inc.
    • Bone Biologics Corp.
Product Code: GVR-1-68038-360-7

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is expected to reach USD 9.3 billion by 2030, registering a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

  • Based on product, the viscosupplementation segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share in the market in 2023 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment accounted for the largest revenue share due to the growing patient population undergoing surgical procedures
  • North America dominated the market due to the presence of several market players and a well-established regulatory framework

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Orthobiologics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Orthobiologics: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Global Orthobiologics Market Segment Analysis, By Product, 2018 - 2030 (USD Billion)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Orthobiologics Market, by Product Type, 2018 to 2030
  • 4.5. Demineralized Bone Matrix (DBM)
    • 4.5.1. Demineralized Bone Matrix (DBM) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Allograft
    • 4.6.1. Allograft market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Bone morphogenetic protein (BMP)
    • 4.7.1. Bone morphogenetic protein (BMP) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.8. Viscosupplementation
    • 4.8.1. Viscosupplementation market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.9. Synthetic bone substitutes
    • 4.9.1. Synthetic bone substitutes market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.10. Stem cell therapy
    • 4.10.1. Stem cell therapy market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Global Orthobiologics Market Segment Analysis, By Application, 2018 - 2030 (USD Billion)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global orthobiologics Market, by Application, 2018 to 2030
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Trauma repair
    • 5.6.1. Trauma repair market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Reconstructive surgery
    • 5.7.1. Reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Global Orthobiologics Market Segment Analysis, By End-use, 2018 - 2030 (USD Billion)

  • 6.1. Definition and Scope
  • 6.2. End-use Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Orthobiologics Market, by end-use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Outpatient facilities
    • 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Global Orthobiologics Market Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Orthobiologics Market Share by Region, 2023 & 2030
  • 7.5. North America
    • 7.5.1. North America orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Canada orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.6. Europe
    • 7.6.1. Europe orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.2. UK
      • 7.6.2.1. UK orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.3. Germany
      • 7.6.3.1. Germany orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.4. France
      • 7.6.4.1. France orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.5. Italy
      • 7.6.5.1. Italy orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.6. Spain
      • 7.6.6.1. Spain orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.7. Norway
      • 7.6.7.1. Norway orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.2. China
      • 7.7.2.1. China orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.3. India
      • 7.7.3.1. India orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.4. Australia
      • 7.7.4.1. Australia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.3. UAE
      • 7.9.3.1. UAE orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait orthobiologics market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. DePuy Synthes
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Zimmer Biomet
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus LLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Seaspine Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Orthofix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Arthrex, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bone Biologics Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 5 Global orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global orthobiologics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 8 North America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 10 North America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 11 U.S. orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 12 U.S. orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 13 U.S. orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 Canada orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 15 Canada orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 16 Canada orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 17 Europe orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 18 Europe orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 19 Europe orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Europe orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 21 Germany orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 22 Germany orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Germany orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 UK orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 25 UK orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 26 UK orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 27 France orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 28 France orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 29 France orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 30 Italy orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Italy orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Italy orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Spain orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Spain orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 35 Spain orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 36 Denmark orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 37 Denmark orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 38 Denmark orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Sweden orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 40 Sweden orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 41 Sweden orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 42 Norway orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 43 Norway orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Norway orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Asia Pacific orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Asia Pacific Orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 47 Asia Pacific orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 China orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 50 China orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 51 China orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Japan orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 53 Japan orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Japan orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 India orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 56 India orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 57 India orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 58 South Korea orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 59 South Korea orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 60 South Korea orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Australia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 62 Australia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 63 Australia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 Thailand orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 65 Thailand Orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 66 Thailand Orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 67 Latin America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 68 Latin America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 69 Latin America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 70 Latin America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 71 Brazil orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 72 Brazil orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 73 Brazil orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 Mexico orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 75 Mexico orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 76 Mexico orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 77 Argentina orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 78 Argentina orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 79 Argentina orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 MEA orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 81 MEA orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 82 MEA orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 83 MEA orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 84 South Africa orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 85 South Africa orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 86 South Africa orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 UAE orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 91 UAE orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 92 UAE orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait orthobiologics market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Orthobiologics market: outlook
  • Fig. 9 Orthobiologics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Orthobiologics market driver impact
  • Fig. 12 Orthobiologics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Orthobiologics market: Product movement analysis
  • Fig. 16 Orthobiologics market: Product outlook and key takeaways
  • Fig. 17 Demineralized bone matrix (DBM) market estimates and forecast, 2018 - 2030
  • Fig. 18 Allograft estimates and forecast, 2018 - 2030
  • Fig. 19 Bone morphogenetic protein (BMP) estimates and forecast, 2018 - 2030
  • Fig. 20 Viscosupplementation estimates and forecast, 2018 - 2030
  • Fig. 21 Synthetic bone substitutes estimates and forecast, 2018 - 2030
  • Fig. 22 Stem cell therapy estimates and forecast, 2018 - 2030
  • Fig. 23 Orthobiologics Market: Application movement Analysis
  • Fig. 24 Orthobiologics market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2018 - 2030
  • Fig. 26 Trauma repair market estimates and forecasts, 2018 - 2030
  • Fig. 27 Reconstructive surgery market estimates and forecasts, 2018 - 2030
  • Fig. 28 Orthobiologics market: End-use movement analysis
  • Fig. 29 Orthobiologics market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 32 Global orthobiologics market: Regional movement analysis
  • Fig. 33 Global orthobiologics market: Regional outlook and key takeaways
  • Fig. 34 North America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Key country dynamics
  • Fig. 47 France orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 China orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 India orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis, 2022 - 2023